Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Global Blood Therapeutics, Inc.    GBT

GLOBAL BLOOD THERAPEUTICS, INC.

(GBT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Electronic Arts, Global Blood fall; Roku, T-Mobile rise

11/06/2020 | 04:22pm EST

NEW YORK (AP) — Stocks that moved heavily or traded substantially Friday:

T-Mobile US Inc., up $6.30 to $123.56.

The wireless carrier handily beat Wall Street's third-quarter profit and revenue forecasts.

Electronic Arts Inc., down $9.14 to $119.19.

The maker of FIFA, Medal of Honor and other video games gave investors a disappointing revenue forecast.

Trade Desk Inc., up $172.04 to $819.34.

The digital-advertising platform blew past Wall Street's third-quarter profit forecasts.

Roku Inc., up $28.30 to $253.36.

The video streaming company reported a surge in active accounts and a surprising profit in the third quarter.

Cloudflare Inc., up $6.47 to $64.47.

The web security and content delivery company beat analysts' third-quarter earnings forecasts.

HubSpot Inc., up $43.84 to $380.05.

The cloud-based marketing and sales software platform reported a surge in new customers and strong third-quarter profits.

Marriott International Inc., up $2.98 to $103.89.

The hotel operator reported surprisingly good earnings as travel demand rebounded in China.

Global Blood Therapeutics Inc., down $22.11 to $38.21.

The biopharmaceutical company reported disappointing third-quarter earnings and revenue.

Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
DEUTSCHE TELEKOM AG -0.73% 14.94 Delayed Quote.-0.10%
ELECTRONIC ARTS INC. 0.04% 139 Delayed Quote.-3.20%
GLOBAL BLOOD THERAPEUTICS, INC. 0.30% 49.92 Delayed Quote.15.26%
ROKU, INC. -2.43% 408.3 Delayed Quote.22.97%
T-MOBILE US 2.08% 127.28 Delayed Quote.-5.61%
All news about GLOBAL BLOOD THERAPEUTICS, INC.
01/07RBC Capital Raises Price Targets on Seven Stocks, Lowers Targets on Four, Ahe..
MT
01/07GLOBAL BLOOD THERAPEUTICS : GBT Announces New Employment Inducement Grants
AQ
01/05GLOBAL BLOOD THERAPEUTICS : GBT Announces Participation at the 39th Annual J.P. ..
AQ
2020GLOBAL BLOOD THERAPEUTICS : Morgan Stanley Adjusts Global Blood Therapeutics PT ..
MT
2020GLOBAL BLOOD THERAPEUTICS : GBT Announces New Employment Inducement Grants
AQ
2020GLOBAL BLOOD THERAPEUTICS : HC Wainwright Starts Global Blood Therapeutics at Bu..
MT
2020GBT Announces New Employment Inducement Grants
GL
2020GLOBAL BLOOD THERAPEUTICS : GBT Presents New Data on the Long-Term and Real-Worl..
AQ
2020GLOBAL BLOOD THERAPEUTICS : GBT Presents Data on New Sickle Cell Disease Pipelin..
AQ
2020GLOBAL BLOOD THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibit..
AQ
More news
Financials (USD)
Sales 2020 122 M - -
Net income 2020 -245 M - -
Net cash 2020 407 M - -
P/E ratio 2020 -12,6x
Yield 2020 -
Capitalization 3 085 M 3 085 M -
EV / Sales 2020 22,0x
EV / Sales 2021 11,7x
Nbr of Employees 352
Free-Float 88,8%
Chart GLOBAL BLOOD THERAPEUTICS, INC.
Duration : Period :
Global Blood Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLOBAL BLOOD THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Average target price 86,28 $
Last Close Price 49,92 $
Spread / Highest target 204%
Spread / Average Target 72,8%
Spread / Lowest Target -9,86%
EPS Revisions
Managers and Directors
NameTitle
Ted W. Love President, Chief Executive Officer & Director
Mark L. Perry Chairman
Nazila Habibizad Senior Vice President-Operations
Jeffrey S. Farrow Chief Financial & Accounting Officer
Brian Cathers Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
GLOBAL BLOOD THERAPEUTICS, INC.15.26%3 085
MODERNA, INC.24.10%51 304
LONZA GROUP AG3.27%49 041
CELLTRION, INC.-12.53%40 715
IQVIA HOLDINGS INC.4.81%36 004
SEAGEN INC.6.06%33 601